Imaging of Lung Cancer Staging: TNM 9 Updates

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations

Abstract

Imaging plays a key role in clinical staging of lung cancer and guiding therapy. A thorough understanding of the staging system including the nomenclature and updates is necessary to tailor treatment plans and optimize patient care. The 9th edition of the Tumor, Node, Metastasis staging system for lung cancer has no changes for T classification and subdivides N2 and M1c categories. In nodal staging, N2 splits into N2a, ipsilateral mediastinal single station involvement and N2b, ipsilateral mediastinal multiple stations involvement. In the staging of multiple extrathoracic metastases, M1c splits into M1c1, multiple extrathoracic metastases in one organ system and M1c2, multiple extrathoracic metastases in multiple organ systems. Awareness of the proposed changes in TNM-9 staging classification is essential to provide methodical and accurate imaging interpretation.

Original languageEnglish (US)
Pages (from-to)410-419
Number of pages10
JournalSeminars in Ultrasound, CT and MRI
Volume45
Issue number6
DOIs
StatePublished - Dec 2024

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint

Dive into the research topics of 'Imaging of Lung Cancer Staging: TNM 9 Updates'. Together they form a unique fingerprint.

Cite this